Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors
Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors
Active, not recruiting · NCT01434316 · Registry updated 2026-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors | Advanced Malignant Solid Neoplasm | Active, not recruiting | Phase 1 | 2026-08-03 | NCT01434316 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |